December 16, 2010 – The "2010 Top 20 Best in KLAS Awards: Software & Professional Services" report from KLAS has been released. The report includes the annual rankings of the best-performing healthcare IT vendors based on more than 17,000 interviews conducted yearly with healthcare providers.

December 16, 2010 – A system designed to improve acute coronary syndrome (ACS) revascularization following percutaneous coronary intervention (PCI) has received CE Mark.

December 15, 2010 – When physicians who are not radiologists refer patients to imaging facilities they own or lease, their patients don’t always benefit, according to a series of studies in Health Affairs.

December 15, 2010 – A guest editorial in the new publication Clinical Investigation highlights dabigatran etexilate as an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.

December 13, 2010 – Two echocardiographs (ECGs) that deliver built-in, bi-directional communication to help customers connect to electronic medical records (EMRs) have been added. The two new ECGs, under Cardiac Science’s Burdick brand, are only available in the United States.

December 13, 2010 – Based on emerging safety information, the pulmonary arterial hypertension (PAH) drug sitaxentan is being voluntarily withdrawn from the market. Pfizer is also discontinuing studies involving sitaxentan (Thelin) worldwide,

December 13, 2010 - One possible explanation for disparities in care for acute coronary syndrome between men and women may be that women are less likely to accept their physician’s recommendation on treatment. The results of the study were reported online today in Annals of Emergency Medicine.

The JenaValve transcatheter aortic valve implantation (TAVI) device.

Aortic stenosis (AS) is one of the most common valvular disorders in older adults, with a prevalence of approximately 8 percent at age 85 (1).

There have only been incremental improvements in intravascular ultrasound (IVUS) over the past decade. However, three new technologies introduced in 2010, and a few more expected to enter trials or be commercialized in 2011, are pushing new frontiers.

Characterizing Plaque

During a time when the U.S. healthcare reform is on the minds of many within the medical community, physicians and hospital administrators are continuously looking for ways to cut spending. One avenue that physicians and hospitals are exploring is to limit the use of expensive medical devices, such as drug-eluting stents (DES).
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now